-
For years, clinicians have been trying to find ways to predict shoulder dystocia (SD), a complication that can have serious consequences for some infants and, on occasion, for the providers who delivered these babies.
-
To investigate the attitudes and practices of health care providers toward intrauterine device (IUD) use in nulliparous women, the authors performed a national survey of both office-based physicians and Title X health care providers from December 2009 to March 2010.
-
In this issue: Drug shortages; metformin and cancer prevention; migraine prevention guidelines; and FDA actions.
-
-
-
Endoscopic hysterectomy and staging has proved to be equivalent to open laparotomy in reference to survival for selected women with endometrial cancer. Increasingly, endoscopic procedures are being performed with robotic assistance under the claim of improved safety and efficacy.
-
Findings of a small study indicate that Shang Ring, a device in development, is safe and acceptable to men, which might aid in increasing access to voluntary adult male circumcision in areas at high risk of HIV.
-
New research indicates that use of magnetic resonance imaging (MRI) is safe for use in women who rely on such contraceptive methods as intrauterine devices (IUDs) and implants, as well as in women who have tubal microimplants inserted during hysteroscopic sterilization.
-
In June 2012, the Centers for Disease Control and Prevention (CDC) released the U.S. Youth Risk Behavior Surveillance Summary (YRBS) for 2011.1 In the first paragraph, say the most significant finding from the report.
-
The Food and Drug Administration (FDA) has cleared the OraQuick In-Home HIV Test for sale directly to consumers, which makes it the first and only rapid over-the-counter (OTC) HIV test approved in the United States.
